Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised. Please note that parcels weighing over 2kg may be sent via courier due to Royal Mail weight restrictions.

Polycal Powder is fat and protein free and low in minerals so is suitable for patents with such dietary restrictions. It is also free from sucrose, lactose, fructose and galactose, so is suitable for patients with such carbohydrate intolerances.Take blood into a grey top fluoride-oxalate tube and label with specimen time and as "FASTING" as well as the usual patient identification requirements. It is important that the patient should have had normal meals during the last 3 days prior to the test and should not have been dieting. Sugar content reduced by 50% from 1st April 2017 so no longer recommended for glucose tolerance tests - consider Polycal®.

Grey / Non-Formulary (undergoing assessment): Work is ongoing and will be reviewed at a future APC meeting.bottle of POLYCAL [manufactured by Nutricia Clinical Care] - 113 mL of Polycal is equivalent to 75g of anhydrous glucose. Polycal Powder dissolves readily in hot and cold drinks. It has a neutral taste and can therefore be added to both sweet and savoury foods or drinks without significantly altering flavour or texture. It is also suitable for use in cooking.

mL of Polycal is required for each kilogram body weight up to a maximum volume of 113 mL of Polycal The supporting prescribing guideline must have been agreed by the relevant secondary care trust D&TC(s) and approved by the Nottinghamshire APC.

Polycal Powder 400g

Once opened, use contents within 1 month. Replace lid firmly after use. Prepare the food per serving and use within 2 hours. The majority of Nutricia's ONS are suitable for vegetarians as defined by The Vegetarian Society. Carminic Acid, a colouring derived from cochineal, may not be acceptable to some patients and is used in the following ONS: Product name Grey / Non-Formulary: Medicines, which the Nottinghamshire APC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.